Skip to main content

Table 1 Comparison of clinical, laboratory and cancer characteristics between groups

From: The effect of anti-cancer and anti-tuberculosis treatments in lung cancer patients with active tuberculosis: a retrospective analysis

variable

TB treatment

n (%)

Lung cancer

n (%)

P value

Demographic

 Age, years

62.1 (25.0–80.0)

65.4 (45.0–83.0)

0.151

 Male, n (%)

29 (93.5)

43 (84.3)

0.220

 BMI (kg/m2)

20.8

21.9

0.024

 Smoker, n (%)

20 (64.5)

28 (54.9)

0.398

Laboratory

 Hypoalbuminemia, n (%)

15 (48.4)

12 (23.5)

0.020

 Anemia, n (%)

12 (38.7)

17 (33.3)

0.627

 Liver dysfunction, n (%)

5 (16.1)

8 (15.7)

0.958

 Renal dysfunction, n (%)

7 (22.6)

12 (23.5)

0.923

 ESR elevation, n (%)

12 (48.0)

13 (32.5)

0.218

Cancer

 Tumor burden, n (%)

28 (90.3)

42 (82.4)

0.328

Type

 Non-small cell, n (%)

25 (80.6)

37 (72.5)

0.635

  Adenocarcinoma

10 (32.3)

17 (33.3)

 

  Squamous cell

15 (48.3)

19 (37.3)

 

  Large cell

0

1 (1.9)

 

 Small cell, n (%)

6 (19.4)

14 (27.5)

 

Stage

 Not evaluable

6 (19.4)

5 (9.8)

0.269

 I, n (%)

0 (0)

2 (3.9)

 

 II, n (%)

2 (6.5)

3 (5.9)

 

 III, n (%)

4 (12.9)

15 (29.4)

 

 IV, n (%)

19 (61.3)

26 (50.9)

 

KPS

84 ± 8

86 ± 9

0.333

  1. Hypoalbuminemia was defined as a serum albumin concentration < 35 g/L. Anemia was defined as a hemoglobin level < 120 g/L in women and < 130 g/L in men. Liver dysfunction was defined as the total bilirubin levels ≥21  μmol/L and/or prothrombin time index < 50% and/or serum alanineaminotransferase > 35u/L and/or serum aspartate aminotransferase > 35 u/L. Renal dysfunction was defined as serum creatinine ≥88 μmol/L. ESR (erythrocyte sedimentation rate) elevation was defined as ESR ≥ 100 mm/h. Tumor burden was defined as tumor was detected by chest computed tomography. KPS Karnofsky performance score